GMED – Globus Medical, Inc.
GMED — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
2.95
Margin Of Safety %
4
Put/Call OI Ratio
0.34
EPS Next Q Diff
0.03
EPS Last/This Y
0.49
EPS This/Next Y
0.49
Price
83.75
Target Price
110.08
Analyst Recom
1.69
Performance Q
-5.27
Upside
3.2%
Beta
1.09
Ticker: GMED
16 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-02 | GMED | 93.78 | 0.35 | 0.51 | 10964 |
| 2026-03-04 | GMED | 90.47 | 0.35 | 0.28 | 10980 |
| 2026-03-05 | GMED | 89.26 | 0.35 | 0.83 | 11011 |
| 2026-03-09 | GMED | 87.87 | 0.35 | 0.27 | 11084 |
| 2026-03-10 | GMED | 86.69 | 0.36 | 0.72 | 11029 |
| 2026-03-11 | GMED | 87.14 | 0.36 | 0.01 | 11078 |
| 2026-03-12 | GMED | 84.55 | 0.35 | 0.03 | 11221 |
| 2026-03-17 | GMED | 88.2 | 0.35 | 0.62 | 11151 |
| 2026-03-18 | GMED | 86.62 | 0.35 | 0.25 | 11159 |
| 2026-03-19 | GMED | 86.32 | 0.35 | 0.31 | 11161 |
| 2026-03-20 | GMED | 86.27 | 0.33 | 0.10 | 11014 |
| 2026-03-23 | GMED | 87.25 | 0.57 | 0.05 | 2448 |
| 2026-03-24 | GMED | 86.19 | 0.47 | 0.04 | 2837 |
| 2026-03-25 | GMED | 87.34 | 0.42 | 0.33 | 3079 |
| 2026-03-26 | GMED | 86.47 | 0.42 | 0.00 | 3060 |
| 2026-03-27 | GMED | 83.7 | 0.34 | 5.36 | 3554 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
16 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | GMED | 95.48 | 34.1 | - | 4.46 |
| 2026-03-02 | GMED | 93.81 | 35.2 | - | 4.46 |
| 2026-03-03 | GMED | 91.71 | 35.2 | - | 4.46 |
| 2026-03-04 | GMED | 90.43 | 35.2 | - | 4.46 |
| 2026-03-05 | GMED | 89.29 | 35.2 | - | 4.46 |
| 2026-03-06 | GMED | 87.11 | 35.2 | - | 4.46 |
| 2026-03-09 | GMED | 87.82 | 35.2 | - | 4.46 |
| 2026-03-10 | GMED | 86.61 | 35.2 | - | 4.46 |
| 2026-03-11 | GMED | 87.16 | 35.2 | - | 4.46 |
| 2026-03-12 | GMED | 84.54 | 35.2 | - | 4.46 |
| 2026-03-13 | GMED | 84.78 | 35.2 | - | 4.46 |
| 2026-03-17 | GMED | 88.20 | 35.2 | - | 4.47 |
| 2026-03-18 | GMED | 86.58 | 35.2 | - | 4.47 |
| 2026-03-19 | GMED | 86.35 | 35.2 | - | 4.47 |
| 2026-03-20 | GMED | 86.25 | 35.2 | - | 4.47 |
| 2026-03-23 | GMED | 87.25 | 35.2 | - | 4.47 |
| 2026-03-24 | GMED | 86.25 | 35.2 | - | 4.47 |
| 2026-03-25 | GMED | 87.34 | 35.2 | - | 4.47 |
| 2026-03-26 | GMED | 86.53 | 35.2 | - | 4.47 |
| 2026-03-27 | GMED | 83.75 | 35.2 | - | 4.47 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | GMED | -0.50 | -5.94 | 4.20 |
| 2026-03-02 | GMED | -0.58 | -1.80 | 4.18 |
| 2026-03-03 | GMED | -0.58 | -1.80 | 4.18 |
| 2026-03-04 | GMED | -0.58 | -1.80 | 4.18 |
| 2026-03-05 | GMED | -0.58 | -1.80 | 4.18 |
| 2026-03-06 | GMED | -0.58 | -1.80 | 4.18 |
| 2026-03-09 | GMED | -0.58 | -1.82 | 4.18 |
| 2026-03-10 | GMED | -0.58 | -1.82 | 4.18 |
| 2026-03-11 | GMED | -0.58 | -1.82 | 2.92 |
| 2026-03-12 | GMED | -0.58 | -1.82 | 2.92 |
| 2026-03-13 | GMED | -0.58 | -1.82 | 2.92 |
| 2026-03-17 | GMED | -0.54 | -1.84 | 2.92 |
| 2026-03-18 | GMED | -0.54 | -1.84 | 2.92 |
| 2026-03-19 | GMED | -0.54 | -1.84 | 2.92 |
| 2026-03-20 | GMED | -0.54 | -1.84 | 2.92 |
| 2026-03-23 | GMED | -0.54 | -1.83 | 2.92 |
| 2026-03-24 | GMED | -0.54 | -1.83 | 2.92 |
| 2026-03-25 | GMED | -0.54 | -1.83 | 2.95 |
| 2026-03-26 | GMED | -0.54 | -1.83 | 2.95 |
| 2026-03-27 | GMED | -0.54 | -1.83 | 2.95 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
20 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
1.03
Avg. EPS Est. Current Quarter
0.92
Avg. EPS Est. Next Quarter
1.06
Insider Transactions
-0.54
Institutional Transactions
-1.83
Beta
1.09
Average Sales Estimate Current Quarter
740
Average Sales Estimate Next Quarter
793
Fair Value
87.2
Quality Score
79
Growth Score
98
Sentiment Score
94
Actual DrawDown %
17.4
Max Drawdown 5-Year %
-47.9
Target Price
110.08
P/E
21.29
Forward P/E
16.9
PEG
1.48
P/S
3.85
P/B
2.47
P/Free Cash Flow
19.22
EPS
3.93
Average EPS Est. Cur. Y
4.47
EPS Next Y. (Est.)
4.96
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
18.3
Relative Volume
0.79
Return on Equity vs Sector %
-15.6
Return on Equity vs Industry %
-0.1
EPS 1 7Days Diff
EPS 1 30Days Diff
0.23
EBIT Estimation
◆
GMED
Healthcare
$83.77
📉
N/A
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
14/20
Pullback
13/25
Volume
9/15
Valuation
18/20
TP/AR
3/10
Options
5/10
RSI
37.7
Range 1M
13.5%
🚀
N/A
Momentum Growth
Ride accelerating trends
WEAK
Momentum
8/25
Growth
16/30
Estimates
7/20
Inst/Vol
1/15
Options
7/10
EPS Yr
12.3%
EPS NY
10.9%
52W%
64.7%
💎
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+22.7% upside
Quality
12/30
Valuation
11/30
Growth
14/25
Stability
7/10
LT Trend
1/5
Upside
+22.7%
Quality
79
MoS
4%
Click a card to see score breakdown
Full Analysis →
Sector: Healthcare
Industry: Medical Devices
Employees: 6000
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
GMED
Latest News
—
Caricamento notizie per GMED…
stock quote shares GMED – Globus Medical, Inc. Stock Price stock today
news today GMED – Globus Medical, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch GMED – Globus Medical, Inc. yahoo finance google finance
stock history GMED – Globus Medical, Inc. invest stock market
stock prices GMED premarket after hours
ticker GMED fair value insiders trading